Latest Breaking News On - Timothye morris - Page 4 : comparemela.com

Aquestive Therapeutics Inc (AQST) Announces Board and Management Changes

Aquestive Therapeutics Inc (AQST) Announces Board and Management Changes
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Kenneth truittTim morrisTimothye morrisDan barberCompany board of directorsAudit committee of the board directorsAquestive therapeutics incChief medical officerAudit committeeChief executive officer

Humanigen Reports Year-End 2021 Financial Results

Press release content from Business Wire. The AP news staff was not involved in its creation.

United statesUnited kingdomCameron durrantTimothye morrisNational institute of allergyNational institutes of healthExchange commissionEuropean unionHumanigen incLancet respiratory medicineNational institutesNational instituteInfectious diseasesEmergency use authorizationImmune effector cell associated neurotoxicityChronic myelomonocytic leukemia

Humanigen, Inc : Humanigen to Present and Participate at Multiple Investor Events in March

Humanigen, Inc. (Nasdaq: HGEN), a clinical-stage biopharmaceutical company focused on preventing and treating an immune hyper-response called 'cytokine storm,' announced today that management will present

New yorkUnited statesCity ofUnited kingdomAdrian kilcoyneCameron durrantTimothye morrisBob atwillTimothy morrisDale chappellHumanigen incCredit suisseGlobal healthcareChief scientific officerNew york cityAnnual roth

Humanigen, Inc : Humanigen to Present at BIO CEO & Investor Conference

Humanigen, Inc. (Nasdaq: HGEN), a clinical-stage biopharmaceutical company focused on preventing and treating an immune hyper-response called 'cytokine storm,' announced today that Timothy E. Morris

Timothye morrisMarriott marquisHumanigen incBiotechnology innovation organizationHost diseaseInvestor relations

Humanigen, Inc : Humanigen Launches Managed Access Program for Lenzilumab

Humanigen, Inc. (Nasdaq: HGEN), a clinical-stage biopharmaceutical company focused on preventing and treating an immune hyper-response called 'cytokine storm,' announced today that lenzilumab is now

United statesUnited kingdomRob foxTimothye morrisAsia pacificPete beldenAndrea aroldiServices divisionAccess program lenzCorporate developmentClinigen groupEuropean unionHumanigen incConsilium strategic communicationsManaged access programExecutive vice president services division